Clinical Trial Goal
To find out:
- The highest dose of LBS-007 that's safe to give
- If LBS-007 is safe and works well to treat ALL or AML that has relapsed or is refractory
You may be able to join this trial if you:
- Are 18 years old or older
- Have ALL or AML that has relapsed or is refractory
- Do not have acute promyelocytic leukemia
- Agree to have other standard tests done to see if you can be in the clinical trial
Trial Details
LBS-007 is a protein kinase inhibitor that targets CDC7.
You’ll get:
You’ll get:
- LBS-007 – The dose you'll get depends on when you start the trial and how safe it has been
You may continue treatment for up to 1 year. You'll have biopsies to see how well the treatment is working. The clinical trial doctors will check your health for 1 year.
The Food and Drug Administration (FDA) has not yet approved LBS-007.
Locations
Sponsors
collaborator: Lin BioScience Pty Ltd, lead: Lin BioScience, Inc
